116 related articles for article (PubMed ID: 24779772)
1. Identifying structural features related to the biological activity of a series of AT1 antagonists from fragment-based drug design.
da C Silva D; Maltarollo VG; Honorio KM
Protein Pept Lett; 2014 Jun; 21(6):542-9. PubMed ID: 24779772
[TBL] [Abstract][Full Text] [Related]
2. Understanding electrostatic and steric requirements related to hypertensive action of AT(1) antagonists using molecular modeling techniques.
da C Silva D; Maltarollo VG; de Lima EF; Weber KC; Honorio KM
J Mol Model; 2014 Jul; 20(7):2231. PubMed ID: 24935104
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, pharmacological evaluation and in silico ADMET prediction of novel substituted benzimidazole derivatives as angiotensin II-AT1 receptor antagonists based on predictive 3D QSAR models.
Vyas VK; Gupta N; Ghate M; Patel S
SAR QSAR Environ Res; 2014; 25(2):117-46. PubMed ID: 24598006
[TBL] [Abstract][Full Text] [Related]
4. QSAR studies on 3-(4-biphenylmethyl) 4, 5-dihydro-4-oxo-3H-imidazo [4, 5-c] Pyridine derivatives as angiotensin II (AT1) receptor antagonist.
Sharma MC
Interdiscip Sci; 2015 Jun; 7(2):113-28. PubMed ID: 26215494
[TBL] [Abstract][Full Text] [Related]
5. 3D QSAR studies on substituted benzimidazole derivatives as angiotensin II-AT1 receptor antagonist.
Vyas VK; Ghate M; Chintha C; Patel P
Curr Comput Aided Drug Des; 2013 Sep; 9(3):433-45. PubMed ID: 24010938
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Potent Antihypertensive Ligands Substituted Imidazolyl Biphenyl Sulfonylureas Analogs as Angiotensin II AT1 Receptor Antagonists by Molecular Modelling Studies.
Sharma MC
Interdiscip Sci; 2015 Sep; 7(3):221-32. PubMed ID: 26188391
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazole derivatives as nonpeptidic angiotensin II AT1 receptor antagonists.
Wang JL; Zhang J; Zhou ZM; Li ZH; Xue WZ; Xu D; Hao LP; Han XF; Fei F; Liu T; Liang AH
Eur J Med Chem; 2012 Mar; 49():183-90. PubMed ID: 22309912
[TBL] [Abstract][Full Text] [Related]
8. Molecular docking, 3D-QSAR and structural optimization on imidazo-pyridine derivatives dually targeting AT1 and PPARg.
Zhang J; Hao QQ; Liu X; Jing Z; Jia WQ; Wang SQ; Xu WR; Cheng XC; Wang RL
Oncotarget; 2017 Apr; 8(15):25612-25627. PubMed ID: 28445965
[TBL] [Abstract][Full Text] [Related]
9. CoMFA and CoMSIA studies of angiotensin (AT1) receptor antagonists.
Datar P; Desai P; Coutinho E; Iyer K
J Mol Model; 2002 Oct; 8(10):290-301. PubMed ID: 12483229
[TBL] [Abstract][Full Text] [Related]
10. QSAR modeling of AT1 receptor antagonists using ANN.
Su Q; Zhou L
J Mol Model; 2006 Sep; 12(6):869-75. PubMed ID: 16541251
[TBL] [Abstract][Full Text] [Related]
11. Homology modeling, binding site identification and docking study of human angiotensin II type I (Ang II-AT1) receptor.
Vyas VK; Ghate M; Patel K; Qureshi G; Shah S
Biomed Pharmacother; 2015 Aug; 74():42-8. PubMed ID: 26349961
[TBL] [Abstract][Full Text] [Related]
12. Development of CoMFA models of affinity and selectivity to angiotensin II type-1 and type-2 receptors.
Sköld C; Karlén A
J Mol Graph Model; 2007 Jul; 26(1):145-53. PubMed ID: 17161636
[TBL] [Abstract][Full Text] [Related]
13. Molecular modeling, quantum polarized ligand docking and structure-based 3D-QSAR analysis of the imidazole series as dual AT(1) and ET(A) receptor antagonists.
Singh KD; Muthusamy K
Acta Pharmacol Sin; 2013 Dec; 34(12):1592-606. PubMed ID: 24304920
[TBL] [Abstract][Full Text] [Related]
14. Nonpeptidic angiotensin II AT₁ receptor antagonists derived from 6-substituted aminocarbonyl and acylamino benzimidazoles.
Zhang J; Wang JL; Yu WF; Zhou ZM; Tao WC; Wang YC; Xue WZ; Xu D; Hao LP; Han XF; Fei F; Liu T; Liang AH
Eur J Med Chem; 2013 Nov; 69():44-54. PubMed ID: 24007859
[TBL] [Abstract][Full Text] [Related]
15. Pharmacophore, drug metabolism, and pharmacokinetics models on non-peptide AT1, AT2, and AT1/AT2 angiotensin II receptor antagonists.
Berellini G; Cruciani G; Mannhold R
J Med Chem; 2005 Jun; 48(13):4389-99. PubMed ID: 15974591
[TBL] [Abstract][Full Text] [Related]
16. Molecular modelling studies for the discovery of new substituted pyridines derivatives with angiotensin II AT1 receptor antagonists.
Sharma MC
Interdiscip Sci; 2014 Sep; 6(3):197-207. PubMed ID: 25205497
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of AT
Wu Z; Anh NTP; Yan YJ; Xia MB; Wang YH; Qiu Y; Chen ZL
Eur J Med Chem; 2019 Nov; 181():111553. PubMed ID: 31369932
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II--AT1 receptor antagonists: design, synthesis and evaluation of substituted carboxamido benzimidazole derivatives.
Shah DI; Sharma M; Bansal Y; Bansal G; Singh M
Eur J Med Chem; 2008 Sep; 43(9):1808-12. PubMed ID: 18158200
[TBL] [Abstract][Full Text] [Related]
19. Pharmacophore modeling of dual angiotensin II and endothelin A receptor antagonists.
Xue WZ; Lü W; Zhou ZM; Wang ZL
Yao Xue Xue Bao; 2009 Sep; 44(9):1002-8. PubMed ID: 20055175
[TBL] [Abstract][Full Text] [Related]
20. The discovery of new potent non-peptide Angiotensin II AT1 receptor blockers: a concise synthesis, molecular docking studies and biological evaluation of N-substituted 5-butylimidazole derivatives.
Agelis G; Resvani A; Durdagi S; Spyridaki K; Tůmová T; Slaninová J; Giannopoulos P; Vlahakos D; Liapakis G; Mavromoustakos T; Matsoukas J
Eur J Med Chem; 2012 Sep; 55():358-74. PubMed ID: 22889560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
